Clinical trial · Observational

The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Ovarian Cancer

The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Epithelial Ovarian Cancer

NCT02856841CI-TRIAL-00023374completedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

44 patients were enrolled in this study as they had malignant epithelial ovarian tumor.Pre-operative staging was assessed by CT scan based on FIGO classification and compared to the standard laparotomy surgical staging. Maximal surgical effort for Optimum cytoreduction was achieved and the risk factors for sub-optimal cytoreduction were studied

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Ovarian Cancer	Malignant Ovarian Neoplasm	CURATED_EXACT	0.92

Interventions

Interventions (0)

Data not yet available

No intervention recorded.

Design

Arms and outcomes

Arms (2)

label
optimum cytoreduction
description
without any gross tumor residue after surgery
label
Suboptimum cytoreduction
description
with any gross tumor residue after surgery

Primary outcomes (1)

measure
feasibility of optimum cytoreduction
timeFrame
1 year after surgery
description
ability to remove all gross lesions from the tumor intraoperatively and leaving no ovarian lesion seen by naked eye of the expert surgeon

Eligibility

Eligibility (as posted)

Sex: Female
Minimum age: 20 Years
Maximum age: 60 Years

Show eligibility criteria text

Inclusion Criteria:

* malignant epithelial ovarian tumor (EOC)

FIGO stage II, III, and IV.

Exclusion Criteria:

* Patients with previous abdominal or pelvic major surgery, synchronous abdominal or pelvic pathology or medically unfit for surgery

References

Publications (0)

Data not yet available

No reference posted for this study.